Bangalore India Bio 2010.
The Bangalore India Bio 2010 conference, held in Bangalore, India, included topics covering new developments in the biopharma industry. This conference report highlights selected presentations on novel therapeutics for the treatment of cancer, including identification of novel benzimidazole, N-subsituted isatin and azetidine derivatives, and an Wnt antagonist. In addition, presentations from several biopharma companies and universities are highlighted, including Proteomics International Pty Ltd, Oxford BioMedica plc, AnaptysBio Inc, SIOGEN Biotech, RV College of Engineering and Indian Institute of Science.
Thammanabhatla
Pratibha
P
Thomson Reuters, Hyderabad, India. pratibhakumari.thammanabhatla@thomsonreuters.com
Pailla
Mamatha
M
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D004345:Drug Industry; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D007194:India; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D015507:Drugs, Investigational